When MSCs are administered via nebulization, they can reach the lungs and exert their therapeutic effects. We also help get them to the brain this way by first administering hyaluronidase to weaken the mucus membrane. This allows MSCs to cross the mucus membrane and enter the carotid artery where they go straight to the brain.
Once in the lungs and brain, MSCs possess the ability to interact with the local immune system and promote tissue repair and regeneration. They can modulate the immune response and reduce inflammation by releasing various signaling molecules and factors. This anti-inflammatory effect is beneficial for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory diseases characterized by inflammation. It is also highly beneficial for brain function for issues such as stroke recovery, traumatic brain injury, autism and Multiple Sclerosis.
MSCs can guide cellular differentiation and regeneration of different cell types, such as lung epithelial cells, which can help in repairing damaged lung tissues. They may also secrete factors that promote tissue healing, enhance the regeneration of damaged cells, and prevent further injury.
Additionally, MSCs have been shown to have potent immunomodulatory effects. They can regulate the immune system’s response, potentially reducing excessive immune reactions and preventing tissue damage.
We use 25 million mesenchymal stem cells for our Nebulized Stem Cell Therapy for Brain Health and Lungs. This stem cell treatment is designed to get the mesenchymal stem cells to the brain and to the lungs.
